Avante Mezzanine Partners is providing debt and equity to support Sverica International’s acquisition of Dexmet Corp. Dexmet is based in Connecticut and develops metals and polymeric materials.
Los Angeles, California – Avante Mezzanine Partners announced today that it has provided subordinated debt and an equity co-invest to support the acquisition of Dexmet Corporation by Sverica International Investment Fund III. Headquartered in Wallingford, Connecticut, Dexmet is the leading developer and manufacturer of highly engineered, expanded metals and polymeric materials. Dexmet’s products function as mission-critical components on aircraft to protect against lightning strikes, on high-performance batteries to support conductivity and structure, and on a variety of other niche applications.
“Avante proved to be an excellent mezzanine partner as they showed flexibility in pricing and structuring, conducted efficient diligence, and delivered on what they promised,” said Dave Finley, a Managing Director at Sverica International. “This was our first deal with Avante and we were impressed with their ability to provide a seamless, one-stop financing solution alongside Abacus Finance.”
“We are thrilled to support Sverica and its acquisition of Dexmet,” said Jeri Harman, Founder and Partner of Avante. “We pride ourselves in building relationships with quality sponsors such as Sverica. Additionally, Dexmet’s dominant market position, defensible niche and attractive growth drivers made it an ideal fit with Avante. We are excited to witness Dexmet’s next stage of growth under Sverica’s experienced guidance and look forward to supporting the company in its future endeavors.”